Voya Investment Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$78.9 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2025	BUY	$12.63 - $24.47 $1.05 Million - $2.04 Million	83,293 Added 209.78%	122,998 $2.91 Million
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $1.05 Million - $2.04 Million	83,293 Added 209.78%	122,998 $2.91 Million
Q3 2023 Feb 07, 2025	BUY	$10.86 - $17.62 $3,572 - $5,796	329 Added 0.84%	39,705 $592,000
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $3,572 - $5,796	329 Added 0.84%	39,705 $592,000
Q2 2023 Feb 07, 2025	BUY	$7.47 - $10.95 $294,138 - $431,167	39,376 New	39,376 $431,000
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $294,138 - $431,167	39,376 New	39,376 $431,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $51,003 - $100,523	-29,653 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $3,737 - $5,322	-1,157 Reduced 3.76%	29,653 $100,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $906,945 - $1.4 Million	-214,408 Reduced 87.44%	30,810 $140,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $3.44 Million - $5.42 Million	-600,281 Reduced 71.0%	245,218 $1.41 Million
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $2.73 Million - $5.95 Million	821,515 Added 3425.26%	845,499 $6.12 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $23,164 - $69,823	-16,429 Reduced 40.65%	23,984 $84,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $925,376 - $4.13 Million	-695,772 Reduced 94.51%	40,413 $79,000
Q3 2019 Nov 14, 2019	SELL	$5.12 - $7.21 $669,998 - $943,493	-130,859 Reduced 15.09%	736,185 $3.77 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $424,111 - $957,579	70,101 Added 8.8%	867,044 $6.21 Million
Q1 2019 May 15, 2019	SELL	$8.16 - $13.42 $1.7 Million - $2.79 Million	-208,096 Reduced 20.71%	796,943 $10.6 Million
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $1.11 Million - $1.99 Million	-169,556 Reduced 14.44%	1,005,039 $7.91 Million
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $2.51 Million - $3.35 Million	230,710 Added 24.44%	1,174,595 $13 Million
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $10.1 Million - $13.6 Million	943,885 New	943,885 $12.7 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account